Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

synedgen, inc. - poly(n-acetyl, n-arginyl)glucosamine (50000-80000 mw) (unii: ua7my2jy0e) (poly(n-acetyl, n-arginyl)glucosamine (50000-80000 mw) - unii:ua7my2jy0e) - poly(n-acetyl, n-arginyl)glucosamine (50000-80000 mw) 1 g in 1 g - derived from chitin obtained from arctic shrimp shells, synoplex® has an approximate molecular weight of 20 to 100 kda. each gram of synoplex® contains 1 gram of poly (acetyl, arginyl) glucosamine. synoplex® is supplied as a dry soluble powder, that is rehydrated with sterile water prior to use. synoplex® acts on the bacterial membrane causing aggregation of bacteria and pore formation leading to reduction of viable bacteria and prevention of biofilm formation.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

vifor (international) inc. - methoxy polyethylene glycol-epoetin beta (unii: lr3uxn0193) (methoxy polyethylene glycol-epoetin beta - unii:lr3uxn0193) - methoxy polyethylene glycol-epoetin beta 30 ug in 0.3 ml - mircera is indicated for the treatment of anemia associated with chronic kidney disease (ckd) in: limitations of use mircera is not indicated and is not recommended: mircera has not been shown to improve symptoms, physical functioning, or health-related quality of life. mircera is contraindicated in patients with: risk summary available data from a small number of published case reports and postmarketing experience with mircera use in pregnancy are insufficient to identify a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. chronic kidney disease is associated with maternal and embryo-fetal risks (see clinical considerations) . in animal reproduction studies, administration of methoxy polyethylene glycol-epoetin beta to rats and rabbits during pregnancy and lactation adversely affected offspring at doses 17-fold and greater than the recommended human dose (see data) . the estimated background risk of major birth defects and miscarriage for the indicated populatio

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750) - polyethylene glycol 3350 240 g in 278.26 g - gavilyte- c with flavor pack is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination. gavilyte- c with flavor pack is contraindicated in patients known to be hypersensitive to any of the components. gavilyte- c with flavor pack is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

lannett company, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium sulfate (unii: 0ypr65r21j) (sodium cation - unii:lyr4m0nh37) - polyethylene glycol 3350 240 g in 4 l - peg-3350 & electrolytes is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination. peg-3350 & electrolytes is contraindicated in patients known to be hypersensitive to any of the components. peg-3350 & electrolytes is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

winco foods, llc - polyvinyl alcohol (unii: 532b59j990) (polyvinyl alcohol - unii:532b59j990), povidone (unii: fz989gh94e) (povidone - unii:fz989gh94e) - polyvinyl alcohol 500 mg in 100 ml - ​purpose polyvinyl alcohol: eye lubricant povidone: eye lubricant uses : - for use as a protectant against further irritation or to relieve dryness of the eye - for the temporary relief of discomfort due to minor irritations of the eye, or to exposure to wind or sun

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

strategic sourcing services llc - polyethylene glycol 400 (unii: b697894sgq) (polyethylene glycol 400 - unii:b697894sgq), propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - polyethylene glycol 400 0.4 g in 100 ml - purpose polyethylene glycol 400............. lubricant propylene glycol............ lubricant uses • for the temporary relief of burning and irritation due to dryness of the eye

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

atlantic biologicals corps - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - for the treatment of occasional constipation. this product should be used for 2 weeks or less or as directed by a physician. polyethylene glycol 3350 nf is contraindicated in patients with known or suspected bowel obstruction and patients known to be allergic to polyethylene glycol.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

oceanside pharmaceuticals - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol-3350, electrolytes, and ascorbate for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. polyethylene glycol-3350, electrolytes, and ascorbate for oral solution is contraindicated in the following conditions: risk summary there are no available data on polyethylene glycol-3350, electrolytes, and ascorbate for oral solution in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with polyethylene glycol-3350, electrolytes, and ascorbate for oral solution. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary the

Kanada - Inggeris - Health Canada

pharma stulln inc. - polysorbate 80 - solution - 0.8% - polysorbate 80 0.8% - artificial tears

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

meda pharmaceuticals - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750) - polyethylene glycol 3350 240 g in 4 l - colyte® with flavor packs is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination. colyte is contraindicated in the following conditions: colyte® (co-light) with flavor packs (peg-3350 & electrolytes for oral solution) read this instructions for use before you start taking colyte. this information does not take the place of talking with your healthcare provider about your medical condition or your treatment. how should i take colyte? colyte can be taken with or without a flavor pack. if you use a flavor pack, complete steps 1 through 8. if you do not use a flavor pack, throw away the flavor packs and complete steps 4 through 8. step 1:  remove the cap from the colyte bottle. step 2:  tear open 1 flavor pack of your choice and pour contents into the colyte bottle. throw away the unused flavor pack. step 3:  replace the cap on the colyte bottle. shake the colyte bottle well to mix the contents of the flavor pack into the powder. step 4:  remove the cap from the colyte bottle.